Emglif-M
Emglif-M (Empagliflozin and Metformin HCl) Tablet is used for the treatment of high blood sugar in patients caused due to type-2 diabetes. It is also effective to lower the risks of death in patients with heart attacks, blood vessel disease, and type-2 diabetes. Emglif-M tablet is composed of two drugs which are Empagliflozin and Metformin.
Empagliflozin is Related to a group of medicines generally known as Sodium-glucose co-transporter inhibitors. It works by inhibiting the absorption of blood sugar in the kidneys. Metformin is generally known as biguanides medication. It works by lowering the blood sugar in the liver and stomach. It guides your body to use sugar in a better way.
Package contains: Each pack of Emglif-M contains 14 tablets of 12.5mg/1000mg. 
Composition:
Each Film coated tablet contains:
Empagliflozin 2.5mg
Metformin Hydrochloride USP 1000mg
Innovator’s Specs
Dosage: As directed by the physician.
Some common side effects of Emglif-M are:
- Weakness
- Nausea
- Headache
- Bloating
- Vomiting
- Diarrhoea
- Stomach upset
Instructions:
Store at 25o C, excursions permitted to 15o C-30o C. Protect from sunlight and moisture. Keep all medicine out of reach of children.
To be sold on the prescription of a registered medical practitioner. See leaflet for full prescribing information.
Manufactured and Buy Online:
Manufactured by: Genix Pharma (Pvt) Ltd: https://www.genixpharma.com
Buy online from: https://qne.com.pk
By: Arslan Aslam